farnesol has been researched along with Acute Brain Injuries in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedito, RB; Costa, JP; da Rocha Tomé, A; de Almeida, RN; de Arruda Torres, P; de Fatima Formiga Melo Diniz, M; de Freitas, RM; de Oliveira Júnior, WM; de Sousa, DP; Pereira, WB; Ramos, CA | 1 |
| Alexandrovich, A; Biegon, A; Elad-Sfadia, G; Grossman, R; Haklai, R; Kloog, Y; Shohami, E; Yatsiv, I | 1 |
| Alexandrovitch, A; Brandeis, R; Goelman, G; Kloog, Y; Marciano, D; Shohami, E | 1 |
3 other study(ies) available for farnesol and Acute Brain Injuries
| Article | Year |
|---|---|
Farnesol: antinociceptive effect and histopathological analysis of the striatum and hippocampus of mice.
Topics: Analgesics; Animals; Brain Injuries; Corpus Striatum; Farnesol; Hippocampus; Male; Mice; Pain Measurement | 2013 |
The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model.
Topics: Animals; Brain Injuries; Disease Models, Animal; Enzyme Inhibitors; Farnesol; Guanosine Triphosphate; Head Injuries, Closed; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neuroprotective Agents; ras Proteins; Receptors, N-Methyl-D-Aspartate; Recovery of Function; Salicylates | 2003 |
Neuroprotective effects of the Ras inhibitor S-trans-trans-farnesylthiosalicylic acid, measured by diffusion-weighted imaging after traumatic brain injury in rats.
Topics: Animals; Brain Injuries; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Farnesol; Male; Motor Activity; ras Proteins; Rats; Recovery of Function; Salicylates; Time Factors | 2007 |